⌘K

Home/Filings/4/0001209191-20-059475

4//SEC Filing

CHALMERS DEREK T 4

Accession 0001209191-20-059475

CIK 0001346830other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 5:29 PM ET

Size

4.9 KB

Accession

0001209191-20-059475

Insider Transaction Report

Form 4

Period: 2020-11-17

Cara Therapeutics, Inc.CARA

CHALMERS DEREK T

DirectorPresident & CEO

Transactions

Sale
Common Stock
2020-11-17$16.00/sh−11,799$188,784→ 941,421 total

Footnotes (1)

[F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1

filerCIK 0001166287

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 5:29 PM ET
Size: 4.9 KB

View on SEC.gov